Researchers develop compound for autism treatment

Researchers develop compound for autism treatment

Bengaluru: A group of researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in Bengaluru has developed a compound called 6BIO that can provide a better method to treat Autism Spectrum Disorder (ASD). The team has already determined the potency of the compound in a preclinical mice model. It says this is the first compound that has been proved in preclinical evaluation to have the potential for improving efficiency of daily activities like learning and recollecting new tasks in patients with ASD/intellectual disability (ID).The research — carried out by Vijaya Verma , MJ Vijay Kumar, Kavita Sharma, Sridhar Rajaram , Ravi Muddashetty , Ravi Manjithaya, Thomas Behnisch and James P Clement from JNCASR — has been published in Experimental Brain Research.“Previous studies have attributed disruption in optimal brain development, mainly neuronal connections, during the early stage of development (babies/childhood) as one of the causes of ASD/ID. Due to altered brain development, information processing becomes aberrant and understanding simple tasks becomes exceptionally challenging for patients with ASD/ID,” the researchers said.Pointing out that current therapeutics to treat ASD aim to alleviate symptoms such as epileptic seizures or sleep issues but not to treat the multiple problems of ASD/ID, they said […]

Click here to view original web page at timesofindia.indiatimes.com

Leave a Reply

Your email address will not be published. Required fields are marked *